These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30522907)

  • 41. School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination.
    Davies C; Stoney T; Hutton H; Parrella A; Kang M; Macartney K; Leask J; McCaffery K; Zimet G; Brotherton JML; Marshall HS; Skinner SR;
    Vaccine; 2021 Jul; 39(30):4190-4198. PubMed ID: 34127299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: A cluster-randomized trial.
    Davies C; Marshall HS; Brotherton JML; McCaffery K; Kang M; Macartney K; Garland SM; Kaldor J; Zimet G; Skinner SR;
    Prev Med; 2023 Jul; 172():107542. PubMed ID: 37172767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving adolescent human papillomavirus (HPV) immunization uptake in school-based health centers through awareness campaigns.
    Rane MS; Page LC; McVeigh E; Miller K; Baure D; Elizabeth Halloran M; Duchin JS
    Vaccine; 2021 Mar; 39(12):1765-1772. PubMed ID: 33640146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.
    Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA
    J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Uptake of Human Papillomavirus Vaccine In Irish Schools: The Impact Of Disadvantage.
    Migone C; Barrett T; Cotter S; Clarke A; Corcoran B
    Ir Med J; 2017 Aug; 110(7):603. PubMed ID: 29341515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk?
    Barbaro B; Brotherton JM
    Aust N Z J Public Health; 2014 Oct; 38(5):419-23. PubMed ID: 24962721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does electronic consent improve the logistics and uptake of HPV vaccination in adolescent girls? A mixed-methods theory informed evaluation of a pilot intervention.
    Chantler T; Pringle E; Bell S; Cooper R; Edmundson E; Nielsen H; Roberts S; Edelstein M; Mounier-Jack S
    BMJ Open; 2020 Nov; 10(11):e038963. PubMed ID: 33148741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia.
    Brotherton JM; Mullins RM
    Cancer Epidemiol; 2012 Jun; 36(3):298-302. PubMed ID: 22204834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women.
    Garcia-Sicilia J; Schwarz TF; Carmona A; Peters K; Malkin JE; Tran PM; Behre U; Iturbe EB; Catteau G; Thomas F; Dobbelaere K; Descamps D; Dubin G;
    J Adolesc Health; 2010 Feb; 46(2):142-51. PubMed ID: 20113920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implementation and Evaluation of a School-Based Human Papillomavirus Vaccination Program in Rural Kentucky.
    Vanderpool RC; Breheny PJ; Tiller PA; Huckelby CA; Edwards AD; Upchurch KD; Phillips CA; Weyman CF
    Am J Prev Med; 2015 Aug; 49(2):317-23. PubMed ID: 26190806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implementation of an HPV vaccination program in Eldoret, Kenya: results from a qualitative assessment by key stakeholders.
    Vermandere H; Naanyu V; Degomme O; Michielsen K
    BMC Public Health; 2015 Sep; 15():875. PubMed ID: 26358701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017.
    Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Regan DG; Hocking JS; Garland SM; Cornall AM; Atchison S; Bradshaw CS; McNulty A; Owen L; Marshall L; Russell DB; Kaldor JM; Chen MY
    Vaccine; 2019 Oct; 37(46):6907-6914. PubMed ID: 31562001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Annual Immunisation Coverage Report 2016.
    Hull B; Hendry A; Dey A; Beard F; Brotherton J; McIntyre P
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human Papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany.
    Blödt S; Holmberg C; Müller-Nordhorn J; Rieckmann N
    Eur J Public Health; 2012 Dec; 22(6):808-13. PubMed ID: 22199161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Missed opportunities for adolescent vaccination, 2006-2011.
    Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA
    J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data.
    McQuaid F; Mulholland R; Sangpang Rai Y; Agrawal U; Bedford H; Cameron JC; Gibbons C; Roy P; Sheikh A; Shi T; Simpson CR; Tait J; Tessier E; Turner S; Villacampa Ortega J; White J; Wood R
    PLoS Med; 2022 Feb; 19(2):e1003916. PubMed ID: 35192611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of determinants associated with uptake of the first dose of the human papillomavirus vaccine in Denmark.
    Amdisen L; Kristensen ML; Rytter D; Mølbak K; Valentiner-Branth P
    Vaccine; 2018 Sep; 36(38):5747-5753. PubMed ID: 30111513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort.
    Sayinzoga F; Umulisa MC; Sibomana H; Tenet V; Baussano I; Clifford GM
    Vaccine; 2020 May; 38(24):4001-4005. PubMed ID: 32336599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine delivery?
    Mendes Lobão W; Duarte FG; Burns JD; de Souza Teles Santos CA; Chagas de Almeida MC; Reingold A; Duarte Moreira E
    PLoS One; 2018; 13(11):e0206726. PubMed ID: 30418980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring school level attributable risk to support school-based HPV vaccination programs.
    Vujovich-Dunn C; Wand H; Brotherton JML; Gidding H; Sisnowski J; Lorch R; Veitch M; Sheppeard V; Effler P; Skinner SR; Venn A; Davies C; Hocking J; Whop L; Leask J; Canfell K; Sanci L; Smith M; Kang M; Temple-Smith M; Kidd M; Burns S; Selvey L; Meijer D; Ennis S; Thomson C; Lane N; Kaldor J; Guy R
    BMC Public Health; 2022 Apr; 22(1):822. PubMed ID: 35468743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.